Hybrid calcium carbonate nanoparticles incorporated with capsaicin for tumor therapy via calcium overload mediated mitochondria damage and endoplasmic reticulum stress
Year: 2025
Type: article
Abstract: Calcium ions (Ca 2+ ) play a critical role in a variety of cellular processes, with excessive intracellular Ca 2+ accumulation triggering cascades that can ultimately lead to cell death. This has prompted the development of calcium overload-based tumor therapies as a promising therapeutic strategy. In this study, we designed a pH-responsive nanoplatform where biocompatible calcium carbonate (CaCO 3 ) nanoparticles served as templates, co-doping with gallic acid (GA) and zinc ions (Zn 2+ ) to form a hollow structure. After PEGylation, the CaCO 3 hollow nanoparticles were utilized as an efficient drug delivery system for capsaicin (CAP), enabling a carrier-passenger synergy by providing Ca 2+ sources and enhancing TRPV1-agonized Ca 2+ influx in the tumor microenvironment, thereby promoting cancer cell apoptosis. The nanoparticles were further camouflaged with tumor-homologous cytomembranes, resulting in CAP/GA-Zn@CaCO 3 -PEG@M nanoparticles (CCaM NPs) with excellent stability and remarkable tumor-targeting ability. In TRPV1-overexpressing cancer cells, CCaM NPs effectively induce calcium overload, triggering three major cytotoxic mechanisms: i) mitochondria damage; ii) endoplasmic reticulum stress (ERS); and iii) cytoskeleton disruption. In both subcutaneous and orthotopic liver tumor models, intravenous administration of CCaM NPs demonstrated potent anti-tumor effects, enhanced tumor-specific accumulation, and favorable biosafety profiles. Overall, our work introduces a hybrid CAP delivery system based on CaCO 3 that modulates cellular calcium homeostasis, offering a synergetic and targeted approach to calcium-overload-directed tumor therapy.
Source: Chemical Engineering Journal
Language: English
Subfield: Biomaterials
Field: Materials Science
Domain: Physical Sciences
Open Access status: hybrid
Estimated APC paid: $4,830
Funders: National Natural Science Foundation of China, National University's Basic Research Foundation of China, National Key Research and Development Program of China, Fundamental Research Funds for the Central Universities, Medical Science and Technology Project of Zhejiang Province, Key Research and Development Program of Zhejiang Province
OpenAlex ID: W4417067427
